The feasibility of using ursodeoxycholic acid in the treatment of patients with non-alcoholic fatty liver disease: a clinical case

Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 3

Abstract

Non-alcoholic fatty liver disease (NAFLD) is on a leading position among chronic liver diseases. In addition, the pathogenesis of NAFLD has not been fully studied for today. Some authors suggest that NAFLD is one of the components of metabolic syndrome (MS), considering it as a liver manifestation of MS. The article presents current views on the treatment of patients with NAFLD. The theoretical aspects of using ursodeoxycholic acid (UDCA) and the possibility of its application in patients with a combination of NAFLD and MS are also presented. As an example, the feasibility and efficacy of UDCA administration to the patient L. with NAFLD and MS (glucose intolerance, arterial hypertension, obesity) has been demonstrated. The prescription of Ursofalk to the patient L. is pathogenetically grounded due to the hypocholesterolemic, cytoprotective, antioxidant, anticholestatic and other its beneficial effects. UDCA can be considered as an effective and safe drug for the treatment of patients not only with NAFLD, but also with MS, diseases of the cardiovascular system and obesity.

Authors and Affiliations

Ye. S. Sirchak

Keywords

Related Articles

Features of Chronic Pancreatitis in Transcarpathia

In the article the analysis of prevalence and incidence parameters for pancreatic diseases, digestive diseases in the general population in Transcarpathia has been carried out. The features of chronic pancreatic diseases...

The Role of Enteropathogenic E.coli in the Development and Progression of Chronic Non-Ulcerative Colitis

Objective. The analysis of the literature has shown that in patients with chronic non-ulcerative colitis, there were isolated E.coli that cause dysentery-like, cholera-like diseases and escherichioses. Thus, the aim of o...

Bioimpedancemetry in Evaluating Nutritional Status of Patients with Chronic Inflammatory Bowel Diseases

The article deals with the study of nutritional status in patients with chronic inflammatory bowel disease (CIBD) using bioimpedancemetry. 40 patients with CIBD were examined. The high prevalence of deviations in the per...

Essential Phospholipids in the Treatment of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) — a metabolic-related disease resulting from insulin resistance, which is characterized by fatty liver degeneration of varying degrees in the absence of other factors of liver inj...

Download PDF file
  • EP ID EP388619
  • DOI 10.22141/2308-2097.52.3.2018.141848
  • Views 77
  • Downloads 0

How To Cite

Ye. S. Sirchak (2018). The feasibility of using ursodeoxycholic acid in the treatment of patients with non-alcoholic fatty liver disease: a clinical case. Гастроентерологія, 52(3), 179-185. https://europub.co.uk/articles/-A-388619